Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
278.3 CHF | -0.32% |
|
+1.27% | +1.42% |
Jun. 13 | AlphaValue/Baader Europe Lowers Price Target on Sonova, Maintains Add Recommendation | MT |
Jun. 10 | SONOVA HOLDING : Beneficiary of innovation quotient via planned product launches | ![]() |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company returns high margins, thereby supporting business profitability.
- Sales forecast by analysts have been recently revised upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The company's enterprise value to sales, at 4.54 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.42% | 18.42B | A | ||
-15.27% | 20.34B | B | ||
-0.07% | 9.32B | B- | ||
-26.80% | 1.82B | - | ||
+7.10% | 1.82B | B+ | ||
+4.16% | 1.3B | D- | ||
-2.33% | 514M | - | ||
0.00% | 334M | - | - | |
+90.14% | 220M | - | ||
+25.74% | 106M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SOON Stock
- Ratings Sonova Holding AG